Agreement signedPublished 8 Oct 2026

Viatris Inc. /
Pacira BioSciences, Inc.

Viatris Inc. signed an agreement for Pacira BioSciences, Inc.

Buy side: Viatris Inc.
Buy sideViatris Inc.
Pacira BioSciences, Inc. · 8 Oct 2026Source
Buy side: Viatris Inc.
Buy sideViatris Inc.
01 / BuyerViatris Inc.
02 / TargetPacira BioSciences, Inc.
Source for the buyer and target: Pacira BioSciences, Inc.

For the buyer and target.

“On October 8, 2026, Pacira BioSciences, Inc., a Delaware corporation (the “Company” or “Pacira”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Viatris Inc., a Delaware corporation (“Parent”), and Peach Purchaser Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Purchaser”).”

Published 8 Oct 2026

Open the source
01

What happened

The deal for Pacira BioSciences, Inc. is signed, with Viatris Inc. as the buyer, at a stated price of $36.50 per Share in cash. [01]

The filing from Pacira BioSciences, Inc. is dated Oct. 8, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Pacira BioSciences, Inc.

Viatris Inc. signed an agreement for Pacira BioSciences, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “The filing from Pacira BioSciences, Inc. is dated Oct. 8, 2026”

    Open the source
  2. Published by Pacira BioSciences, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.